- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02251405
Behaviour Intervention to Decrease Melamine Exposure (Bidme)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study subjects:
Two tiers:
- Recruit 88 student volunteers from two university buildings and collect their morning one-spot urine specimens for 3 consecutive days (44 students in each building (Building A and Building B)
- Select appropriate study subjects with high excretion of urinary melamine and with consuming melamine tableware containing hot water or hot soup by questionnaire in the past 3 days for intervention.
Study protocol:
This is a cluster randomized crossover intervention. We will conduct this study for 9 days and each experimental step lasts for 3 days. We randomly assign one building with 8 appropriate study subjects to a serial of control-intervention-intervention steps and another building with also 8 appropriate study subjects to a serial of control-control-intervention steps. Intervention step means study subjects will carry one big bag containing two stainless containers, one stainless spoon, and one stainless chopstick and use them for each meal during the trial (Some subjects will need to take pictures randomly and email back before the meal). Control means study subjects will carry one big bag without those stainless container, spoon, and chopstick and only use the containers provided by vendors for each meal during the trial (Some subjects will need to take pictures randomly and email back before the meal to check their adherence). Collect 24-hr urine samples for 9 days for melamine levels.
Inclusion criteria: 20-30 healthy students Exclusion criteria: Subjects with cancer, hypertension, diabetes, chronic hepatic or renal diseases, including urinary tract infection, or renal stones; Family history of renal stones; Body weight less than 50 kg.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kaohsiung, Taiwan, 807
- Kaohsiung Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 20-30-yrs healthy students
Exclusion Criteria:
- Subjects with cancer, hypertension, diabetes, chronic hepatic or renal diseases, renal stones;
- Family history of renal stones;
- Body weight less than 50 kg.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: One big bag, no stainless container
No stainless container
|
|
|
Active Comparator: One big bag with two stainless containers
Two stainless containers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Decrease melamine excretion
Time Frame: 3 days
|
3 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ming-Tsang Wu, MD, ScD, Kaohsiung Medical University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- KMU-DT103004 (Other Identifier: Kaohsiung Medical University Hospital)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subjects
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
PfizerCompletedHealthy Adult Subjects and Healthy Elderly SubjectsBelgium
-
PfizerCompletedHealthy Subjects | Healthy ParticipantsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Healthy Subjects | ImmunosuppressionUnited States
-
Lund UniversityCompletedHealthy Subjects | Diet, HealthySweden
-
Vichy LaboratoiresCentre de Pharmacologie Clinique Applique a la DermatologieCompletedHealthy Subjects | Healthy AdultFrance
-
Yuhan CorporationNot yet recruiting
-
Central Hospital, Nancy, FranceNot yet recruitingHealthy SubjectsFrance
-
Lutroo Imaging LLCStanford UniversityRecruiting
Clinical Trials on One bag, stainless container
-
Harran UniversityCompletedPost Operative Pain | Chronic Apical Periodontitis of Pulpal OriginTurkey (Türkiye)
-
Hospital General de Niños Pedro de ElizaldeTerminated
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCompletedNasopharyngeal Carcinoma | Brain NecrosisChina
-
Columbia UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
University of ArizonaUnknownType 2 Diabetes Mellitus